Second HealthTech call

25 January 2023

Based on the strength of the first Joint Call HealthTech, the Ministry of the Economy, the National Research Fund and Luxinnovation join forces again to further build the collaboration culture between companies, research and healthcare organisations. This includes matching HealthTech products or services at prototype stage with research and healthcare expertise to co-develop and validate these solutions at a clinical level for the benefit of patients and deliver leading innovation.

Call open from 1 February 2023 to 31 March 2023.

Innovative digital health solutions

The overall goal of this new joint healthtech call is the development and validation of innovative digital health solutions benefiting the national healthcare (patients, healthcare professionals, payers), research and innovation ecosystems.

The joint call intends to incentivise collaborative R&D projects for improvement of health and care delivery focused on medical evidence, harnessing the opportunities of digital health (mHealth, telemonitoring, AI, personalised medicine…) in order to enable a patient-centred healthcare.

It also aims to provide a financial incentive to consortia who have a specific digital product or service at prototype stage for which they wish to demonstrate its relevance and benefit for human health and society.

Topic of the call

Proposed solutions through this call should include the use of digital tools to improve prevention, diagnosis, monitoring or treatment of health conditions to improve public health or to increase patient autonomy, such as at home or in a care home environment.

Products to be developed through this call must be innovative digital health solutions for human use that (1) are already at prototype stage and that can meet at least one of (2a) or (2b):

• (2a) are or will be regulated by the medical device regulation (MDR)² or in-vitro medical device regulation (IVDR)³. (Examples: digital medical devices, digital health applications, connected medical devices)
• (2b) that will apply innovative data processing or analysis techniques on real world data from healthcare or care environments to prove a societal impact. 

In line with national priorities seeking to develop personalised medicine further, and in line with strategic intentions to build a data innovation service platform, consortia will have to align to the following approaches:

• Innovative clinical investigations: centred on taking the current state of the art in clinical trials and refining their design and implementation through innovative means such as digital tools, smart wearables and sensors, electronic medical record analysis, and other precision medicine approaches. These clinical trials should bring added value to patients.
• Multifactorial intervention strategies: focused on designing and testing interventions that are not molecular in nature, for example through lifestyle and digital means. The goal is to improve health through innovative, participatory, and personalised intervention strategies, resulting in health-associated impact through interdisciplinary research.

HealthTech call: information sessions

A webinar series presenting the objectives of the Joint Call HealthTech as well as the process of preparing applications, is organised. First session will be held on 2023, February 1 and will followed by a Q&A session.

🔴 Webinars | Joint call HealthTech – Information sessions

Take the opportunity to learn more about the objectives and modalities of the call.

Visit the Joint calls platform and register to the webinars 👉 https://t.co/fLTQFRG6Fv pic.twitter.com/DBx97VOo3t

— Luxinnovation (@Luxinnovation) January 20, 2023

Similar articles